Company
Nuvation Bio
Nuvation Bio is a global oncology company focused on tackling some of the toughest challenges in cancer treatment.
Also known as Nuvation Bio, Inc.
- Status
- Operatingas of 2026-09-21
- Founded
- 2018
- Legal name
- Nuvation Bio, Inc.
- nuvationbio.com (opens in a new tab)
- LinkedIn (opens in a new tab)
- Press page (opens in a new tab)
- Careers (opens in a new tab)
Claim, correct or request removal
Record updated 28 September 2026
About
Our mission is to develop therapies that create a profound, positive impact on patients’ lives. We challenge conventional thinking with a bold, patient-first mindset, driving meaningful progress in cancer treatment and fearlessly tackling challenges others may not. We lead with compassion, transparency, and passion to deliver treatments that redefine cancer care.
Funding snapshot
- Total raised
- $275MSEC form D sum, as of 2026-09-28Source (opens in a new tab)
- Latest round
- Round, $275M2019-06-17
Funding rounds
- Round, 2019
- $275M2019-06-17, SEC form D sold, 57 investors
Products
- Other
- IBTROZI (taletrectinib)
Loading relationship preview